Gender Equality

February 29, 2024 Alnylam Named to Human Rights Campaign’s Corporate Equality Index Alnylam has achieved a score of 90 out of 100 on the Human Rights Campaign's (HRC) 2023-2024 Corporate Equality Index (CEI) based on our US policies, practices, Read More ›
March 29, 2023 Leading by Example in Gender Diversity Among Executive Leadership Alnylam ranked #1 among MA public companies in board of directors gender diversity and #3 in executive leadership gender diversity in the 2023 WPG report.   Read More ›
January 31, 2023 Alnylam Named to Bloomberg's Gender-Equality Index for 3rd Year in a Row Alnylam has been named to Bloomberg's Gender Equality Index (GEI) for the 3rd year in a row. Read More ›
January 26, 2022 Alnylam Named to Bloomberg's Gender-Equality Index for 2nd Year in a Row Alnylam has been named to Bloomberg's 2022 Gender-Equality Index (GEI) - an important diversity, equity and inclusion benchmark, for the 2nd year in a row. Read More ›
September 28, 2021 Alnylam Named a Best Workplace for Working Mothers and Fathers Alnylam has been named a 100 Best Companies (formerly Working Mother's Top 100 Companies) and Best Companies for Dads lists for 2021. Find out why. Read More ›
February 6, 2021 Alnylam Named to Bloomberg's 2021 Gender-Equality Index Alnylam has been selected to Bloomberg's Gender-Equality Index for 2021 Read More ›
March 6, 2020 IWD 2020: Alnylam Women Reflect on Personal Experiences & Inspiration We asked Alnylam women from across the globe to share to share a personal experience or inspiration that has shaped how they view gender and science at work. Read More ›
February 19, 2020 Making Strides in Gender Parity Alnylam ranked #3 in gender parity and #1 in fair representation for Women of Color (WOC) in Executive and Board Leadership among the top 25 employers in MA. Read More ›

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site